Want to join the conversation?
Healthcare diagnostics company $LH said that VENTANA PD-L1 Assay, a new immunotherapy treatment for patients with urothelial cancer, a form of bladder cancer, is available in the US. The test was developed by Roche Diagnostics and was approved on May 18, 2016 by the FDA to identify patients who could benefit from treatment with $NDA's TECENTRIQ.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!